Candriam S.C.A. Applied Therapeutics Inc. Call Options Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLT
# of Institutions
139Shares Held
114MCall Options Held
1.62MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$97.8 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$91.9 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$91.2 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$74.3 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$63.1 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $446M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...